Cara Therapeutics reported $15.22M in Trade Creditors for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Acadia Pharmaceuticals ACAD:US USD 10.01M 1.85M
Acelrx Pharmaceuticals ACRX:US USD 2M 397K
Aerie Pharmaceuticals AERI:US USD 9.06M 217K
Cara Therapeutics CARA:US USD 15.22M 5.48M
Depomed DEPO:US USD 8.37M 1.04M
Endo International Ordinary Shares ENDP:US USD 85M 5.64M
Halozyme Therapeutics HALO:US USD 18.17M 5.93M
Horizon Pharma HZNP:US USD 32.11M 13.58M
Pacira Pharmaceuticals PCRX:US USD 12.93M 1.05M
Pain Therapeutics PTIE:US USD 3.53M 1.22M
Revance Therapeutics RVNC:US USD 744K 12.53M
Supernus Pharmaceuticals SUPN:US USD 16.02M 19.5M
Teva Pharmaceutical Industries TEVA:US USD 1.64B 266M
Vanda Pharmaceuticals VNDA:US USD 5.58M 36K